Graves' Disease: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
 
   
<div class="noeditbox">Welcome to [[Pathophysiology of Complex Patient Problems|PT 635 Pathophysiology of Complex Patient Problems]] This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!</div> <div class="editorbox">
<div class="noeditbox">Welcome to [[Pathophysiology of Complex Patient Problems|PT 635 Pathophysiology of Complex Patient Problems]] This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!</div> <div class="editorbox">
'''Original Editors '''- Erin Shinkle [[Pathophysiology of Complex Patient Problems|from Bellarmine University's&nbsp;Pathophysiology of Complex Patient Problems project.]]  
'''Original Editors '''- Erin Shinkle [[Pathophysiology of Complex Patient Problems|from Bellarmine University's&nbsp;Pathophysiology of Complex Patient Problems project.]]  
Line 7: Line 7:
== Definition/Description  ==
== Definition/Description  ==


Graves’ is classified as an autoimmune disease that affects the thyroid gland. It causes goiters, hyperthyroidism, ophthalmopathy, and occasionally dermopathy.(ginsberg) Graves'&nbsp; disease is known for increasing the thyroid stimulating hormone raising the T4 levels which leads to hyperthyroidism symptoms.(DD) Hyperthyroidism/Graves' disease can manifest itself in multiple systems(link to hyperthyroidism page).<br>
Graves’ is classified as an autoimmune disease that affects the thyroid gland. It causes goiters, hyperthyroidism, ophthalmopathy, and occasionally dermopathy.(ginsberg) Graves'&nbsp; disease is known for increasing the thyroid stimulating hormone raising the T4 levels which leads to hyperthyroidism symptoms.(DD) Hyperthyroidism/Graves' disease can manifest itself in multiple systems(link to hyperthyroidism page).<br>  


== Prevalence  ==
== Prevalence  ==
Line 13: Line 13:
Graves’ disease is more prevalent in the Caucasian race affecting more women than men at a ratio of 4:1 and ages range from 30-60years (Hemmiki and DD). Graves’ disease accounts for 85% of all cases of hyperthyroidism. (Pathology)  
Graves’ disease is more prevalent in the Caucasian race affecting more women than men at a ratio of 4:1 and ages range from 30-60years (Hemmiki and DD). Graves’ disease accounts for 85% of all cases of hyperthyroidism. (Pathology)  


<br>
<br>  


== Characteristics/Clinical Presentation  ==
== Characteristics/Clinical Presentation  ==


Goiter, Exophthalmos, tremors, tachycardia with palpitations, heat intolerances, weight loss, increased deep tendon reflexes, weakness and muscle atrophy, increased cardiac output, myasthenia gravis, thin hair, warm moist skin, sensitivity to light, dysphasia, diarrhea, amenorrhea, polyuria, and many other presentations some of which may not be as common and more subtle. (pathology)<br>
Goiter, Exophthalmos, tremors, tachycardia with palpitations, heat intolerances, weight loss, increased deep tendon reflexes, weakness and muscle atrophy, increased cardiac output, myasthenia gravis, thin hair, warm moist skin, sensitivity to light, dysphasia, diarrhea, amenorrhea, polyuria, and many other presentations some of which may not be as common and more subtle. (pathology)<br>  


== Associated Co-morbidities  ==
== Associated Co-morbidities  ==
Line 23: Line 23:
Rhuematoid arthritis is one of the major associated autoimmune diseases but a raise in incidence for a co-morbidity of any autoimmune diseases. (Boelaert) Rexommendation for futher autoimmune disease screening may occur with the diagnosis of Graves' disease.&nbsp;  
Rhuematoid arthritis is one of the major associated autoimmune diseases but a raise in incidence for a co-morbidity of any autoimmune diseases. (Boelaert) Rexommendation for futher autoimmune disease screening may occur with the diagnosis of Graves' disease.&nbsp;  


<br>


 
There is also an increased risk of  
There is also an increased risk of


== Medications  ==
== Medications  ==
Line 35: Line 35:
Thyroid blood serum testsare taken A positive test results include a decreased or normal TSH levels, elevated free thyroxine t4 diagnosis of hyperthyriodism. To specify graves disease Radioiodine uptake test is used.(Ginsberg)  
Thyroid blood serum testsare taken A positive test results include a decreased or normal TSH levels, elevated free thyroxine t4 diagnosis of hyperthyriodism. To specify graves disease Radioiodine uptake test is used.(Ginsberg)  


Thyroid stimulating Hormone Antibodies (TRAb) and thyroid peroxidase autoantibodies (TPOAb) may be found in most patients, but is not needed for specific diagnosis since most patients are diagnosed with blood serum tests and symptomology. (Fukushima)
Thyroid stimulating Hormone Antibodies (TRAb) and thyroid peroxidase autoantibodies (TPOAb) may be found in most patients, but is not needed for specific diagnosis since most patients are diagnosed with blood serum tests and symptomology. (Fukushima)  


== Etiology/Causes  ==
== Etiology/Causes  ==


Has both a genetic, lack of suppressor t-cells causing increase in TSH receptor antibodies, and environmental causes which includes, but not limited to the following: stress, smoking, post pardum, and infections (Hemminki and ginsburg)<br><br>
Has both a genetic, lack of suppressor t-cells causing increase in TSH receptor antibodies, and environmental causes which includes, but not limited to the following: stress, smoking, post pardum, and infections (Hemminki and ginsburg)<br><br>  


== Systemic Involvement  ==
== Systemic Involvement  ==
Line 47: Line 47:
== Medical Management (current best evidence)<br>  ==
== Medical Management (current best evidence)<br>  ==


The current best management of Graves' disease varies upon several factors of the individual recieving it. The options include partial and full removal of thyroid gland, antithyroid drug therapy, and radioiodine therapy (franklyn).
The current best management of Graves' disease varies upon several factors of the individual recieving it. The options include partial and full removal of thyroid gland, antithyroid drug therapy, and radioiodine therapy (franklyn).  


== Physical Therapy Management (current best evidence)  ==
== Physical Therapy Management (current best evidence)  ==
Line 63: Line 63:
== Case Reports/ Case Studies  ==
== Case Reports/ Case Studies  ==


add links to case studies here (case studies should be added on new pages using the [[Template:Case Study|case study template]])<br>
add links to case studies here (case studies should be added on new pages using the [[Template:Case Study|case study template]])  
 
== Related Articles from Pubmed  ==


== Resources <br>  ==
== Resources <br>  ==


National Graves' Disease Foundation<br>
National Graves' Disease Foundation<br>  


&nbsp; &nbsp;&nbsp;&nbsp; http://www.ngdf.org/<br>
&nbsp; &nbsp;&nbsp;&nbsp; http://www.ngdf.org/<br>  


<br>American Thyroid Association (ATA) <br>
<br>American Thyroid Association (ATA) <br>  


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://thyroid.org/<br> <br>American Association of Clinical Endocrinologists (AACE)<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://thyroid.org/<br> <br>American Association of Clinical Endocrinologists (AACE)<br>  


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.aace.com/<br> <br>The Endocrine Society<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.aace.com/<br> <br>The Endocrine Society<br>  


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.endo-society.org/<br><br>The Hormone Foundation<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.endo-society.org/<br><br>The Hormone Foundation<br>  


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.hormone.org/<br> <br>American Autoimmune Related Diseases Associations (AARDA)<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.hormone.org/<br> <br>American Autoimmune Related Diseases Associations (AARDA)<br>  


&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.aarda.org/
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; http://www.aarda.org/  


<br>
<br>  


<h2> Recent Related Research (from <a href="http://www.ncbi.nlm.nih.gov/pubmed/">Pubmed</a>) </h2>
== ==
<p><br />
</p>


<br>


<br>


== References  ==
== References  ==

Revision as of 00:58, 30 March 2011

 

Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Original Editors - Erin Shinkle from Bellarmine University's Pathophysiology of Complex Patient Problems project.

Lead Editors - Your name will be added here if you are a lead editor on this page.  Read more.

Definition/Description[edit | edit source]

Graves’ is classified as an autoimmune disease that affects the thyroid gland. It causes goiters, hyperthyroidism, ophthalmopathy, and occasionally dermopathy.(ginsberg) Graves'  disease is known for increasing the thyroid stimulating hormone raising the T4 levels which leads to hyperthyroidism symptoms.(DD) Hyperthyroidism/Graves' disease can manifest itself in multiple systems(link to hyperthyroidism page).

Prevalence[edit | edit source]

Graves’ disease is more prevalent in the Caucasian race affecting more women than men at a ratio of 4:1 and ages range from 30-60years (Hemmiki and DD). Graves’ disease accounts for 85% of all cases of hyperthyroidism. (Pathology)


Characteristics/Clinical Presentation[edit | edit source]

Goiter, Exophthalmos, tremors, tachycardia with palpitations, heat intolerances, weight loss, increased deep tendon reflexes, weakness and muscle atrophy, increased cardiac output, myasthenia gravis, thin hair, warm moist skin, sensitivity to light, dysphasia, diarrhea, amenorrhea, polyuria, and many other presentations some of which may not be as common and more subtle. (pathology)

Associated Co-morbidities[edit | edit source]

Rhuematoid arthritis is one of the major associated autoimmune diseases but a raise in incidence for a co-morbidity of any autoimmune diseases. (Boelaert) Rexommendation for futher autoimmune disease screening may occur with the diagnosis of Graves' disease. 


There is also an increased risk of

Medications[edit | edit source]

add text here

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

Thyroid blood serum testsare taken A positive test results include a decreased or normal TSH levels, elevated free thyroxine t4 diagnosis of hyperthyriodism. To specify graves disease Radioiodine uptake test is used.(Ginsberg)

Thyroid stimulating Hormone Antibodies (TRAb) and thyroid peroxidase autoantibodies (TPOAb) may be found in most patients, but is not needed for specific diagnosis since most patients are diagnosed with blood serum tests and symptomology. (Fukushima)

Etiology/Causes[edit | edit source]

Has both a genetic, lack of suppressor t-cells causing increase in TSH receptor antibodies, and environmental causes which includes, but not limited to the following: stress, smoking, post pardum, and infections (Hemminki and ginsburg)

Systemic Involvement[edit | edit source]

add text here

Medical Management (current best evidence)
[edit | edit source]

The current best management of Graves' disease varies upon several factors of the individual recieving it. The options include partial and full removal of thyroid gland, antithyroid drug therapy, and radioiodine therapy (franklyn).

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Alternative/Holistic Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Related Articles from Pubmed[edit | edit source]

Resources
[edit | edit source]

National Graves' Disease Foundation

      http://www.ngdf.org/


American Thyroid Association (ATA)

       http://thyroid.org/

American Association of Clinical Endocrinologists (AACE)

       http://www.aace.com/

The Endocrine Society

       http://www.endo-society.org/

The Hormone Foundation

        http://www.hormone.org/

American Autoimmune Related Diseases Associations (AARDA)

         http://www.aarda.org/


[edit | edit source]



References[edit | edit source]

see adding references tutorial.